CLINICAL_TRIALS
trial_result
· 2012-11-16
Clinical Trial Update: Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006 [Phase 3]
Summary
A Phase 3 trial of Phenoptin in phenylketonuria patients who participated in PKU-004 or PKU-006 has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonuria | Phase 3 | Status: COMPLETED | Results posted: 2012-11-16